Advantage Trust CO Novartis Ag Transaction History
Advantage Trust CO
- $170 Billion
- Q4 2024
A detailed history of Advantage Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Advantage Trust CO holds 36 shares of NVS stock, worth $3,953. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36Holding current value
$3,953% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,432Shares Held
134MCall Options Held
1.12MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.32 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$889 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$767 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$634 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $236B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...